HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of a leukemia-associated antigen (CAMAL) in four myeloid leukemia cell lines.

Abstract
We have previously described the detection and partial characterization of a common myelogenous leukemia-associated antigen (CAMAL), in CGL and ANLL patients. Both polyclonal and monoclonal (CAMAL-1) antibodies have been raised to p70 (CAMAL) and have been shown to react with both p70 and myeloid leukemia cell preparations. p70 (CAMAL) has been shown to be a monomeric protein of Mr 70,000 and pI 7.2 and was also detectable in the myeloid leukemia cell lines HL60, KG1, K562 and U937, but not in the lymphocytic cell lines Molt-4, Hut-78 and CEM by immunoprecipitation from iodinated cell samples. Using [35S] methionine-labeled cell lines and immunoprecipitation, we have demonstrated the constitutive expression of p70 as well as a major component at p58 and a number at lower molecular weights in the myeloid leukemia cell lines HL60, KG1, K562 and U937, but not in the lymphocytic leukemia cell lines Molt-4, Hut-78 and CEM. The implications of these observations are discussed.
AuthorsR C Shipman, J G Levy
JournalLeukemia research (Leuk Res) Vol. 12 Issue 7 Pg. 537-43 ( 1988) ISSN: 0145-2126 [Print] England
PMID3172816 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Monoclonal
  • Antigens, Differentiation, Myelomonocytic
  • Biomarkers, Tumor
  • Iodine Radioisotopes
  • Sulfur Radioisotopes
  • common myelogenous leukemia-associated antigen
  • Methionine
Topics
  • Antibodies, Monoclonal
  • Antigen-Antibody Reactions
  • Antigens, Differentiation, Myelomonocytic (immunology, isolation & purification)
  • Biomarkers, Tumor (isolation & purification)
  • Cell Fractionation
  • Cell Line
  • Humans
  • Iodine Radioisotopes
  • Leukemia, Myeloid (metabolism)
  • Methionine
  • Molecular Weight
  • Precipitin Tests
  • Sulfur Radioisotopes

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: